Naomi Suriel
Obstetrics & Gynecology · Beverly Hills, CANPI 1538234141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 352 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 37 manufacturers reported payments, led by AbbVie at 26.5% of the total. 2025 is the largest year on record at $1,539, 2.3 times the $676 reported in 2019. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 352 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Daiichi Sankyo Inc.$1K
- Evofem Biosciences, Inc.$517
- Exeltis, USA Inc.$460
- Bayer$444
- Coopersurgical, Inc.$319
- plus $2K from 31 others
What the payments were for
- Food & beverage$6,90298%
- Education$1502%
- Gifts$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $1,869 |
| Daiichi Sankyo Inc. | 49 | $1,024 |
| Evofem Biosciences, Inc. | 40 | $517 |
| Exeltis, USA Inc. | 22 | $460 |
| Bayer | 19 | $444 |
| Coopersurgical, Inc. | 16 | $319 |
| Astellas Pharma US Inc | 9 | $300 |
| Hologic Sales And Service, LLC | 11 | $243 |
| Mayne Pharma Commercial LLC | 8 | $233 |
| Sage Therapeutics, LLC | 10 | $194 |
| Ascend Therapeutics US, LLC | 8 | $169 |
| Sumitomo Pharma America, Inc. | 8 | $160 |
| Therapeuticsmd, Inc. | 10 | $156 |
| Myovant Sciences Inc. | 9 | $152 |
| Pfizer | 5 | $98 |
| Agile Therapeutics, Inc. | 5 | $93 |
| Exact Sciences | 3 | $70 |
| Merck | 3 | $69 |
| Meditrina | 3 | $56 |
| Baxter Healthcare | 1 | $49 |
| Vertical Pharmaceuticals, LLC | 3 | $46 |
| Shield Therapeutics Inc | 2 | $44 |
| Millicent US Inc | 2 | $44 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Amgen | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Aspira Women's Health Inc | 1 | $19 |
| BD | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Minerva Surgical, Inc | 1 | $16 |
| Mission Pharmacal Company | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Lupin Inc. | 1 | $14 |
| Covidien LP | 1 | $11 |
| Channel Medsystems, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,054 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $3,891 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Beverly Hills
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.